Patient Care

Augmedix Announces Participation in Upcoming Investor Conferences

SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers ambient medical documentation…

1 year ago

Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope

Study Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic Devices SILVER SPRING, Md., May…

1 year ago

New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias

Data from three abstracts highlight the potential of an optimized radiofrequency ablation technique for pulmonary vein isolation (PVI)Preservation of raw…

1 year ago

TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

Company prioritizes education with a variety of in-person and virtual training programsMALVERN, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- TELA…

1 year ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

ACTON, Mass., May 19, 2023 (GLOBE NEWSWIRE) --  Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology…

1 year ago

Mass General Brigham and Dana-Farber Cancer Institute collaborating with BEEAH Group to advise on a new, patient-centered health care system

Strategic collaboration supports BEEAH in creating Jawaher Boston Medical District in Sharjah, United Arab EmiratesBoston, MA, May 12, 2023 (GLOBE…

1 year ago

Palisade Bio Reports First Quarter 2023 Financial Results

Company has sufficient cash expected to fund operations through 2024 Carlsbad, CA, May 12, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq:…

1 year ago

Augmedix Delivers Continued Sales Momentum; Reports First Quarter 2023 Financial Results

SAN FRANCISCO, May 12, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical…

1 year ago

Scotiabank donates $1.35M to the MUHC Foundation to create a Montreal without hepatitis C

The transformative gift supports Montréal sans HépC, an ambitious community-based program to prevent and cure hepatitis C cases in Montreal…

1 year ago

Avalyn Pharma Showcasing Therapeutic Approach and Clinical Status at ATS 2023 and the Respiratory Innovation Summit (RIS)

- Avalyn CEO to Present in Company Showcase and Moderate Panel Discussion at ATS RIS - - Results from Long-Term…

1 year ago